BESSI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.463
EU - Europa 3.463
AS - Asia 1.672
SA - Sud America 158
OC - Oceania 82
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.861
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.441
RU - Federazione Russa 1.725
HK - Hong Kong 644
IT - Italia 538
SG - Singapore 421
IE - Irlanda 344
SE - Svezia 257
CN - Cina 230
BR - Brasile 144
PL - Polonia 136
IN - India 132
DE - Germania 109
FI - Finlandia 96
ID - Indonesia 84
AU - Australia 81
JO - Giordania 69
GB - Regno Unito 60
NL - Olanda 59
FR - Francia 48
KR - Corea 30
AT - Austria 18
CA - Canada 17
UA - Ucraina 16
TR - Turchia 13
CH - Svizzera 10
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 8
BE - Belgio 6
AZ - Azerbaigian 5
ES - Italia 5
JP - Giappone 5
PK - Pakistan 5
VN - Vietnam 5
ZA - Sudafrica 5
AR - Argentina 4
IQ - Iraq 4
LV - Lettonia 4
UZ - Uzbekistan 4
BD - Bangladesh 3
BG - Bulgaria 3
GR - Grecia 3
KZ - Kazakistan 3
LU - Lussemburgo 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
IL - Israele 2
KE - Kenya 2
LI - Liechtenstein 2
MA - Marocco 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
SA - Arabia Saudita 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MX - Messico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
TJ - Tagikistan 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.861
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.079
Hong Kong 573
Ashburn 442
Fairfield 364
Dublin 344
Chandler 324
Singapore 264
Seattle 178
Houston 162
Woodbridge 159
Warsaw 135
Wilmington 119
Cambridge 117
Altamura 116
Lawrence 108
Florence 90
Moscow 89
Jakarta 84
Melbourne 78
Mumbai 65
Princeton 62
Helsinki 54
Ann Arbor 53
Buffalo 51
Bremen 50
Shanghai 49
Dearborn 43
New York 43
Beijing 41
Boston 40
Bengaluru 38
San Diego 37
Boardman 33
Medford 33
Kent 31
Paris 27
Seoul 27
Los Angeles 24
Pune 21
Milan 20
West Jordan 20
Lappeenranta 19
Rome 19
Dallas 18
Jacksonville 18
São Paulo 13
Yubileyny 13
Falls Church 12
London 12
Nuremberg 12
Toronto 12
Abidjan 10
Frankfurt am Main 10
Izmir 9
Vienna 9
Hillsboro 8
Naples 8
Cedar Knolls 7
Chicago 7
Falkenstein 7
Guangzhou 7
Prato 7
Brussels 6
Genoa 6
Lambeth 6
Romola 6
Zurich 6
Cagliari 5
Düsseldorf 5
Norwalk 5
Perugia 5
Turku 5
Arezzo 4
Baku 4
Belo Horizonte 4
Chennai 4
Dong Ket 4
Fiesole 4
Hefei 4
Kunming 4
Menlo Park 4
Munich 4
Portsmouth 4
Prescot 4
Riga 4
Rio de Janeiro 4
Tampa 4
Taranto 4
The Dalles 4
Almaty 3
Andover 3
Bari 3
Bologna 3
Campi Bisenzio 3
Como 3
Council Bluffs 3
Duncan 3
Fuzhou 3
Kilburn 3
L’Aquila 3
Totale 7.080
Salva come PNG Salva come JPEG
Nome #
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 309
Correlati Neurali del Deficit Mnesico: Studio VBM e DTI in soggetti affetti da Disturbo Soggettivo di Memoria, Mild Cognitive Impairment e Malattia di Alzheimer 195
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 157
Acute Symptomatic Sinus Bradycardia in High-Dose Methylprednisolone Therapy in a Woman With Inflammatory Myelitis: A Case Report and Review of the Literature 153
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study 149
Association analysis of the paraoxonase-1 gene with Alzheimer's disease 147
A case of atypical early-onset Alzheimer’s disease carrying the missense mutation Thr354Ile in exon 10 of the PSEN1 gene 143
From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study 142
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 137
Pattern and progression of cognitive decline in Alzheimer's disease:role of premorbid intelligence and ApoE genotype 136
Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease 135
Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation 133
KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment 132
A new national survey of centers for cognitive disorders and dementias in Italy 129
Implication of serotonin-transporter (5-HTT) gene polymorphism in subjective memory complaints and mild cognitive impairment (MCI). 125
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11-year follow-up study 125
Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity 123
The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study 122
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 122
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 115
Crossed aphasia in nonfluent variant of primary progressive aphasia carrying a GRN mutation 114
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease 112
Mutation analysis of patients with neurodegenerative disorders using NeuroX array 111
Early functional MRI changes in a prodromal semantic variant of primary progressive aphasia: a longitudinal case report 110
Suitability of neuropsychological tests in patients with vascular dementia (VaD). 109
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 109
Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease 109
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F-fluorodesoxyglucose-positron emission tomography 109
Semantic dementia associated with mutation V363I in the tau gene. 107
A Pan-European study of theC9orf72Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability and Intermediate Repeats 107
Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease. 106
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort 106
Behavioral and psychological effects of coronavirus disease-19 quarantine in patients with dementia 106
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 106
Per2 C111G polymorphism influences cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. A 10-year follow-up study 105
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 103
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 103
Crossed aphasia confirmed by fMRI in a case with nonfluent variant of primary progressive aphasia carrying a GRN mutation 102
Tomm40 polymorphisms in Italian Alzheimer’s disease and frontotemporal dementia patients 101
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 100
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 100
Education modulates brain maintenance in presymptomatic frontotemporal dementia 98
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 95
Cholesteryl ester transfer protein (CETP) I405V polymorphism in Italian memory complainers 91
Being the Family Caregiver of a Patient With Dementia During the Coronavirus Disease 2019 Lockdown 90
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 88
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 87
Creutzfeldt-Jakob Disease in a Patient with Previous COVID-19 Infection: "The Virus Caused the Derangement in My Brain" 86
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements 86
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 86
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 85
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 85
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 84
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 84
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 83
Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes 81
Brain metabolic connectivity reconfiguration in the semantic variant of primary progressive aphasia 81
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 81
The Frequency of Intermediate Alleles in Patients with Cerebellar Phenotypes 80
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 80
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 80
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 80
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 79
Emotional dysregulation, alexithymia and neuroticism: a systematic review on the genetic basis of a subset of psychological traits 78
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 78
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 78
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 76
Differential early subcortical involvement in genetic FTD within the GENFI cohort 76
Alzheimer Disease detection from Raman spectroscopy of the cerebrospinal fluid via topological machine learning 73
BPSDiary study protocol: a multi-center randomized controlled trial to compare the efficacy of a BPSD diary vs. standard care in reducing caregiver's burden 73
Multiple Electroencephalogram Recordings for Monitoring the Evolution of Neurological Complications during Baclofen Withdrawal Syndrome 73
Alice in wonderland syndrome “through the looking-glass” in a rare presentation of non-convulsive status epilepticus in cerebral venous sinus thrombosis and COVID-19 72
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 72
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 70
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 70
New insights into the genetic etiology of Alzheimer's disease and related dementias 70
Multilayered Bioorthogonal SERS Nanoprobes Selectively Aggregating in Human Fluids: A Smart Optical Assay for β-Amyloid Peptide Quantification 70
Putative novel CSF biomarkers of Alzheimer’s disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort 69
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 67
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 67
Intermediate alleles of HTT: A new pathway in longevity 67
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 67
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum? 67
Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies 67
Citrate-capped gold nanoparticles as colorimetric sensors for amyloid ßpeptide (1-42) targeting in liquid samples 66
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice 66
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol 64
Heterogeneity and overlap in the continuum of linguistic profile of logopenic and semantic variants of primary progressive aphasia: a Profile Analysis based on Multidimensional Scaling study 64
GRN Missense Variants and Familial Alzheimer’s Disease: Two Case Reports 64
Comprehensive qualitative characterization of linguistic performance profiles in primary progressive aphasia: a multivariate study with FDG-PET 63
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 63
null 63
Parkinson-ALS with a novel MAPT variant 62
Regional analysis of the magnetization transfer ratio of the brain in mild Alzheimer disease and amnestic mild cognitive impairment 62
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 61
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns 61
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 60
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment 60
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 60
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 59
Totale 9.532
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.146
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 0 0 0 0 0 0 0 0 0 43 21
2020/2021382 42 28 24 36 14 31 12 28 59 43 33 32
2021/2022469 11 15 34 16 9 25 9 56 30 19 95 150
2022/20231.560 143 340 79 152 90 258 206 72 168 10 31 11
2023/20241.177 30 64 94 45 67 113 69 431 30 118 80 36
2024/20256.253 207 669 394 981 1.778 1.013 139 411 267 259 135 0
Totale 11.026